Figure 6
Infection risk reduction (in %) with Delta variant 14–60 days after vaccination after one or two doses of either BNT162b2 or ChAdOx1 nCoV-19 vaccines.
Figure 6 | Scientific Reports
Infection risk reduction (in %) with Delta variant 14–60 days after vaccination after one or two doses of either BNT162b2 or ChAdOx1 nCoV-19 vaccines.
